AAAAAA

   
Results: 1-25 | 26-50 | 51-74 |
Results: 51-74/74
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas
Authors: Press, OW Eary, JF Gooley, T Gopal, AK Liu, S Rajendran, JG Maloney, DG Petersdorf, S Bush, SA Durack, LD Martin, PJ Fisher, DR Wood, B Borrow, JW Porter, B Smith, JP Matthews, DC Appelbaum, FR Bernstein, ID
Citation: Ow. Press et al., A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, BLOOD, 96(9), 2000, pp. 2934-2942
Cyclosporine (CSP) or CSP pins methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial
Authors: Deeg, HJ Flowers, MED Leisenring, W Appelbaum, FR Martin, PJ Storb, RF
Citation: Hj. Deeg et al., Cyclosporine (CSP) or CSP pins methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial, BLOOD, 96(3), 2000, pp. 1194-1195
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
Authors: Slovak, ML Kopecky, KJ Cassileth, PA Harrington, DH Theil, KS Mohamed, A Paietta, E Willman, CL Head, DR Rowe, JM Forman, SJ Appelbaum, FR
Citation: Ml. Slovak et al., Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study, BLOOD, 96(13), 2000, pp. 4075-4083
Thalidomide for treatment of patients with chronic graft-versus-host disease
Authors: Koc, S Leisenring, W Flowers, MED Anasetti, C Deeg, HJ Nash, RA Sanders, JE Witherspoon, RP Appelbaum, FR Storb, R Martin, PJ
Citation: S. Koc et al., Thalidomide for treatment of patients with chronic graft-versus-host disease, BLOOD, 96(12), 2000, pp. 3995-3996
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age
Authors: Deeg, HJ Shulman, HM Anderson, JE Bryant, EM Gooley, TA Slattery, JT Anasetti, C Fefer, A Storb, R Appelbaum, FR
Citation: Hj. Deeg et al., Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age, BLOOD, 95(4), 2000, pp. 1188-1194
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome
Authors: Tallman, MS Andersen, JW Schiffer, CA Appelbaum, FR Feusner, JH Ogden, A Shepherd, L Rowe, JM Francois, C Larson, RS Wiernik, PH
Citation: Ms. Tallman et al., Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome, BLOOD, 95(1), 2000, pp. 90-95
Mechanisms of cure of acute myeloid leukemia with allogeneic transplantation
Authors: Appelbaum, FR
Citation: Fr. Appelbaum, Mechanisms of cure of acute myeloid leukemia with allogeneic transplantation, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 403-412
Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia
Authors: Li, Q Kopecky, KJ Mohan, A Willman, CL Appelbaum, FR Weick, JK Issa, JPJ
Citation: Q. Li et al., Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia, CLIN CANC R, 5(5), 1999, pp. 1077-1084
P73 mutations and expression in adult de novo acute myelogenous leukemia
Authors: Stirewalt, DL Clurman, B Appelbaum, FR Willman, CL Radich, JP
Citation: Dl. Stirewalt et al., P73 mutations and expression in adult de novo acute myelogenous leukemia, LEUKEMIA, 13(7), 1999, pp. 985-990
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia
Authors: Karanes, C Kopecky, KJ Head, DR Grever, MR Hynes, HE Kraut, EH Vial, RH Lichtin, A Nand, S Samlowski, WE Appelbaum, FR
Citation: C. Karanes et al., A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia, LEUK RES, 23(9), 1999, pp. 787-794
Molecular diagnosis and clinical decisions in adult acute leukemia
Authors: Appelbaum, FR
Citation: Fr. Appelbaum, Molecular diagnosis and clinical decisions in adult acute leukemia, SEM HEMATOL, 36(4), 1999, pp. 401-410
Treatment of acute myeloid leukemia - Reply
Authors: Cassileth, PA Appelbaum, FR Wiernik, PH
Citation: Pa. Cassileth et al., Treatment of acute myeloid leukemia - Reply, N ENG J MED, 340(18), 1999, pp. 1438-1438
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
Authors: Martin, PJ Rowley, SD Anasetti, C Chauncey, TR Gooley, T Petersdorf, EW van Burik, J Flowers, MED Storb, R Appelbaum, FR Hansen, JA
Citation: Pj. Martin et al., A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, BLOOD, 94(7), 1999, pp. 2192-2199
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology
Authors: Silver, RT Woolf, SH Hehlmann, R Appelbaum, FR Anderson, J Bennett, C Goldman, JM Guilhot, F Kantarjian, HM Lichtin, AE Talpaz, M Tura, S
Citation: Rt. Silver et al., An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology, BLOOD, 94(5), 1999, pp. 1517-1536
Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
Authors: Matthews, DC Appelbaum, FR Eary, JF Fisher, DR Durack, LD Hui, TE Martin, PJ Mitchell, D Press, OW Storb, R Bernstein, ID
Citation: Dc. Matthews et al., Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome, BLOOD, 94(4), 1999, pp. 1237-1247
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study
Authors: Leith, CP Kopecky, KJ Chen, IM Eijdems, L Slovak, ML McConnell, TS Head, DR Weick, J Grever, MR Appelbaum, FR Willman, CL
Citation: Cp. Leith et al., Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study, BLOOD, 94(3), 1999, pp. 1086-1099
Choosing the source of stem cells for allogeneic transplantation: No longer a peripheral issue
Authors: Appelbaum, FR
Citation: Fr. Appelbaum, Choosing the source of stem cells for allogeneic transplantation: No longer a peripheral issue, BLOOD, 94(2), 1999, pp. 381-383
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
Authors: Holmberg, LA Boeckh, M Hooper, H Leisenring, W Rowley, S Heimfeld, S Press, O Maloney, DG McSweeney, P Corey, L Maziarz, RT Appelbaum, FR Bensinger, W
Citation: La. Holmberg et al., Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation, BLOOD, 94(12), 1999, pp. 4029-4035
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia
Authors: Clift, RA Radich, J Appelbaum, FR Martin, P Flowers, MED Deeg, HJ Storb, R Thomas, ED
Citation: Ra. Clift et al., Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia, BLOOD, 94(11), 1999, pp. 3960-3962
Marrow ablative and immunosuppressive effects of I-131-anti-CD45 antibody in congenic and H2-mismatched murine transplant models
Authors: Matthews, DC Martin, PJ Nourigat, C Appelbaum, FR Fisher, DR Bernstein, ID
Citation: Dc. Matthews et al., Marrow ablative and immunosuppressive effects of I-131-anti-CD45 antibody in congenic and H2-mismatched murine transplant models, BLOOD, 93(2), 1999, pp. 737-745
The impact of obesity and disease on busulfan oral clearance in adults
Authors: Gibbs, JP Gooley, T Corneau, B Murray, G Stewart, P Appelbaum, FR Slattery, JT
Citation: Jp. Gibbs et al., The impact of obesity and disease on busulfan oral clearance in adults, BLOOD, 93(12), 1999, pp. 4436-4440
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate
Authors: Sievers, EL Appelbaum, FR Spielberger, RT Forman, SJ Flowers, D Smith, FO Shannon-Dorcy, K Berger, MS Bernstein, ID
Citation: El. Sievers et al., Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate, BLOOD, 93(11), 1999, pp. 3678-3684
The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults
Authors: Banker, DE Radich, J Becker, A Kerkof, K Norwood, T Willman, C Appelbaum, FR
Citation: De. Banker et al., The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults, CLIN CANC R, 4(12), 1998, pp. 3051-3062
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
Authors: Cassileth, PA Harrington, DP Appelbaum, FR Lazarus, HM Rowe, JM Paietta, E Willman, C Hurd, DD Bennett, JM Blume, KG Head, DR Wiernik, PH
Citation: Pa. Cassileth et al., Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission, N ENG J MED, 339(23), 1998, pp. 1649-1656
Risultati: 1-25 | 26-50 | 51-74 |